Pre-evaluation | Post-evaluation | |||||||
Control | Experimental | Control | Experimental | |||||
X | SD | X | SD | X | SD | X | SD | |
Physical limitations | 63.8 | 18.9 | 65.8 | 17.5 | 98.9 | 5.2 | 100 | 5.2 |
Symptom | 77.3 | 22.5 | 72.2 | 22.4 | 80.5 | 19.9 | 83.9 | 19.9 |
Symptom frequency | 83.3 | 21.7 | 75.3 | 25.4 | 81.8 | 22.9 | 88.9 | 22.9 |
Symptom severity | 76.1 | 22.9 | 74.4 | 20.4 | 80.1 | 17.7 | 78.6 | 17.7 |
Symptom evolution | 62.2 | 37.3 | 59.5 | 37.0 | 74.4 | 30.8 | 82.6 | 30.8 |
Self-efficacy | 63.6 | 24.4 | 70.8 | 16.9 | 67.4 | 19.6 | 71.0 | 19.6 |
Quality of life | 54.6 | 22.0 | 61.8 | 18.4 | 82.7 | 12.6 | 81.8 | 12.6 |
Social interference | 61.0 | 31.4 | 67.0 | 29.0 | 99.4 | 3.3 | 99.1 | 3.3 |
Functional state | 71.3 | 18.0 | 69.8 | 18.0 | 90.0 | 9.3 | 92.5 | 9.3 |
Clinical summary | 67.0 | 15.8 | 67.8 | 16.8 | 89.0 | 8.3 | 91.0 | 8.3 |